MTAP antibody (AA 97-196)
Quick Overview for MTAP antibody (AA 97-196) (ABIN7877264)
Target
See all MTAP AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 97-196
-
Purpose
- MTAP Antibody / S-methyl-5'-thioadenosine phosphorylase
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 97-196 from the human protein was used as the immunogen for the MTAP antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the MTAP antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the MTAP antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- MTAP (Methylthioadenosine phosphorylase (MTAP))
-
Alternative Name
- MTAP
-
Background
- Recognizes a protein of 31 kDa, which is identified as MTAP (5'-deoxy-5'-methylthioadenosine phosphorylase). It catalyzes the reversible phosphorolysis of methylthioadenosine, which is important in polyamine metabolism and for the salvage of adenine and methionine. The gene encoding MTAP is linked to the tumor suppressor gene, p16INK4A. Deficient levels of MTAP can occur in cancers primarily through co-deletion of the MTAP gene and the p16INK4A gene. Cells expressing MTAP and possessing adenine salvage pathway activity may be less susceptible to malignancy due to growth-inhibitory actions of agents (e.g. antifolates), whose mechanism of action, in part, involves this de novo purine pathway.
-
UniProt
- Q13126
-
Pathways
- Ribonucleoside Biosynthetic Process, Methionine Biosynthetic Process
Target
-